Share
Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013?2017) (in English)
Y. Robert Li
(Author)
·
Aimsci Inc.
· Paperback
Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013?2017) (in English) - Li, Y. Robert
$ 103.96
$ 129.95
You save: $ 25.99
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Wednesday, July 31 and
Thursday, August 01.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013?2017) (in English)"
Written in an accessible style and consistent format, "Cardiovascular Medicine: New Therapeutic Drugs Approved by the US FDA (2013-2017)" takes a unique approach to integrating the fundamental concepts with high quality cutting-edge research discoveries and translating essential bioscience to evidence-based clinical medicine so as to provide the reader a comprehensive picture of this rapidly evolving field in a concise manner. Blends basic and clinical sciences needed to effectively demonstrate the importance of the field Includes full-color illustrations to facilitate the understanding of the essential concepts Cites references mostly from highly influential journals to ensure the top quality of the information Uses chapter highlights and self-assessment questions to enhance the assimilation of the cutting-edge knowledge Serves as a valuable reference or textbook for students, faculty, clinicians, and other health professionals in the fields of biomedical science, pharmacology, pharmacotherapeutics, and clinical medicine
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
